Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea · Delayed Price · Currency is KRW 6,030.00
+20.00 (0.33%)
At close: Dec 19, 2025
Kyongbo Pharmaceutical Market Cap
Kyongbo Pharmaceutical has a market cap or net worth of 144.16 billion as of December 19, 2025. Its market cap has decreased by -19.71% in one year.
Market Cap
144.16B
Enterprise Value
263.64B
Revenue
252.20B
Ranking
n/a
PE Ratio
60.99
Stock Price
6,030.00
Market Cap Chart
Since June 29, 2015, Kyongbo Pharmaceutical's market cap has decreased from 818.81B to 144.16B, a decrease of -82.39%. That is a compound annual growth rate of -15.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 144.16B | -3.05% |
| Dec 30, 2024 | 148.70B | -25.86% |
| Dec 28, 2023 | 200.58B | -16.10% |
| Dec 29, 2022 | 239.07B | -6.98% |
| Dec 30, 2021 | 257.00B | -34.25% |
| Dec 30, 2020 | 390.88B | 97.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.22T |
| Celltrion | 40.37T |
| ALTEOGEN | 23.96T |
| ABL Bio | 10.29T |
| SK Biopharmaceuticals | 10.09T |
| Yuhan | 8.64T |
| LigaChem Biosciences | 6.25T |
| HLB Co., Ltd. | 6.10T |